Viewing StudyNCT00514085



Ignite Creation Date: 2024-05-05 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00514085
Status: COMPLETED
Last Update Posted: 2023-08-04
First Post: 2007-08-08

Brief Title: Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma
Sponsor: NCIC Clinical Trials Group
Organization: Canadian Cancer Trials Group

Conditions & Keywords Data

Conditions:
Name
Melanoma Skin
Keywords:
Name View
stage IV melanoma View
recurrent melanoma View